Catch up on stories from the past week (and beyond) at the Slashdot story archive

 



Forgot your password?
typodupeerror

Slashdot videos: Now with more Slashdot!

  • View

  • Discuss

  • Share

We've improved Slashdot's video section; now you can view our video interviews, product close-ups and site visits with all the usual Slashdot options to comment, share, etc. No more walled garden! It's a work in progress -- we hope you'll check it out (Learn more about the recent updates).

×
Biotech

+ - US court sides with gene patents-> 2

Submitted by
ananyo
ananyo writes "Gene patents have been upheld in a landmark case over two genes associated with hereditary forms of breast and ovarian cancer.
The lawsuit against Myriad Genetics, a diagnostic company, based in Salt Lake City, Utah, that holds patents on the genes BRCA1 and BRCA2, has bounced from court to court since 2010. In a 2-1 decision today, a federal appeals court reaffirmed their latest decision that genes represent patent-eligible matter. As noted before on slashdot, the case will have major implications for cancer researchers, patients and drug makers."

Link to Original Source
This discussion was created for logged-in users only, but now has been archived. No new comments can be posted.

US court sides with gene patents

Comments Filter:

It is not for me to attempt to fathom the inscrutable workings of Providence. -- The Earl of Birkenhead

Working...